Clinical Trial Update: Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating intravitreal triamcinolone acetonide for refractory diffuse diabetic macular edema; sponsor is Federal University of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Diabetic Retinopathy | Phase 1, Phase 2 | Status: UNKNOWN